HUMAN ANTICHIMERIC ANTIBODY POSITIVE

This adverse event was reported 336 times

These drugs are most commonly taken by patients reporting HUMAN ANTICHIMERIC ANTIBODY POSITIVE:

# Drug Count
0 TOCILIZUMAB 310
1 INFLIXIMAB 309
2 ETANERCEPT 307
3 METHOTREXATE SODIUM 307
4 ABATACEPT 306
5 ADALIMUMAB 305
6 SULFASALAZINE 304
7 ANAKINRA 302
8 METHOTREXATE 292
9 PREDNISONE 290
See all common drugs associated with HUMAN ANTICHIMERIC ANTIBODY POSITIVE

HUMAN ANTICHIMERIC ANTIBODY POSITIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TRIAMCINOLONE HEXACETONIDE 134 0.5115
1 TETANUS IMMUNE GLOBULIN (HUMAN) 16 0.1468
2 VACCINIA IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 3 0.0341
3 ANAKINRA 302 0.0179
4 TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% 139 0.0057
5 IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 34 0.0053
6 NAPROXEN SODIUM 220MG 69 0.0050
7 TRIAMCINOLONE ACETONIDE 139 0.0043
8 SULFASALAZINE 304 0.0041
9 ADALIMUMAB-FKJP 185 0.0040
See all drugs enriched for association with HUMAN ANTICHIMERIC ANTIBODY POSITIVE

HUMAN ANTICHIMERIC ANTIBODY POSITIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-1 Receptor Antagonist [EPC] 302 0.0179
1 Human Immunoglobulin G [EPC] 85 0.0040
2 Aminosalicylate [EPC] 305 0.0030
3 Interleukin-6 Receptor Antagonist [EPC] 310 0.0022
4 Selective T Cell Costimulation Modulator [EPC] 306 0.0022
5 Folate Analog Metabolic Inhibitor [EPC] 292 0.0007
6 Tumor Necrosis Factor Blocker [EPC] 325 0.0003
7 Corticosteroid [EPC] 300 0.0002
8 Vitamin D [EPC] 62 0.0002
9 Vitamin B12 [EPC] 62 0.0002
See all drug classes enriched for association with HUMAN ANTICHIMERIC ANTIBODY POSITIVE